Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-240-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110216.11.3-240-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Ladies and gentlemen, the amount of falsified medicines entering the EU is growing at a terrific rate. This is a particular worry for countries like Lithuania, which forms part of the EU’s eastern border. Eastern Europe is the main route of the trade in falsified medicines worth billions. This is a major problem – the Commission puts the number of boxes of falsified medicines sold within the legal supply chain each year in Europe at 1.5 million. Even more alarming is the fact that volumes are increasing by up to 20%. Falsified medicines are silent killers. The people distributing them are dangerous criminals and should be viewed as such. Penalties for counterfeiting medicine should be the same as for drug trafficking. This will require improved coordination between various national and international institutions. We must clamp down on the sale of falsified medicines online, because the Internet is one of the main routes for falsified medicinal products to enter the European market. According to the World Health Organisation, 50% of the medicines sold online are falsified. I believe that one of our priorities should be to draw the public’s attention to the risks involved in buying medicines online."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples